Comparison with the results observed in the whole BC series and in each of the other subtype (Additional file 7: Table S4) revealed that the prognostic features were the same in the CL subtype and in the whole series, totally different between the CL and the other proliferative subtypes (basal, ERBB2-enriched and luminal B). This evidence concerns the gene ERBB2 and breast cancer.